The cost of delaying treatment in multiple sclerosis - What is lost is not regained

被引：35
|
作者：
Schwid, SR
Bever, CT
机构：
[1] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA
[2] VAMHCS Baltimore, Neurol Serv, Baltimore, MD USA
[3] VAMHCS Baltimore, Res Serv, Baltimore, MD USA
[4] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA
来源：
NEUROLOGY | 2001年 / 56卷 / 12期
关键词：
D O I：
10.1212/WNL.56.12.1620
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1620 / 1620
页数：1
相关论文
共 50 条
  • [1] The cost of delaying treatment in multiple sclerosis: What is lost is not regained
    Barton, J
    Benatar, M
    NEUROLOGY, 2002, 58 (04) : 668 - 668
  • [2] What is New in the Treatment of Multiple Sclerosis?
    Bianca Weinstock-Guttman
    Lawrence D. Jacobs
    Drugs, 2000, 59 : 401 - 410
  • [3] What is new in the treatment of multiple sclerosis?
    Weinstock-Guttman, B
    Jacobs, LD
    DRUGS, 2000, 59 (03) : 401 - 410
  • [4] Progressive multiple sclerosis 2 Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
    Feinstein, Anthony
    Freeman, Jenny
    Lo, Albert C.
    LANCET NEUROLOGY, 2015, 14 (02): : 194 - 207
  • [5] Multiple sclerosis: predicting risk and delaying progression
    Yeh, E. Ann
    Weinstock-Guttman, Bianca
    LANCET NEUROLOGY, 2010, 9 (01): : 7 - 9
  • [6] Multiple sclerosis treatment in Greece: Cost and benefit
    Karageorgiou, E. E.
    Sotirli, S.
    Giannoulis, C.
    Polyzoi, M.
    Tarla, P.
    Logiotatos, N.
    Papageorgiou, H.
    Karageorgiou, C. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 281 - 281
  • [7] A milestone in multiple sclerosis treatment: what changed in the landscape of the multiple sclerosis treatment with oral medications
    Ozakbas, S.
    Cinar, B. Piri
    Yorgun, Y. Guven
    Kahraman, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 925 - 925
  • [8] The cost of medication and the cost of treatment are not the same thing for multiple sclerosis
    Fragoso, Yara Dadalti
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (08) : 499 - 500
  • [9] Modern multiple sclerosis treatment - what is approved, what is on the horizon
    Pilz, Georg
    Wipfler, Peter
    Ladurner, Gunther
    Kraus, Joerg
    DRUG DISCOVERY TODAY, 2008, 13 (23-24) : 1013 - 1025
  • [10] Cost analysis of methylprednisolone treatment of multiple sclerosis patients
    Robson, LS
    Bain, C
    Beck, S
    Guthrie, S
    Coyte, PC
    O'Connor, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 25 (03) : 222 - 229
12345